When was Yuimedi founded?

Yuimedi was founded in 2020 and raised its 1st funding round 2 years after it was founded.

Where is Yuimedi located?

Yuimedi is headquartered in Minato City, Japan.

How many employees does Yuimedi have?

As of Jun 30, 2026, the latest employee count at Yuimedi is 15.

Is Yuimedi a funded company?

Yuimedi is a funded company, having raised a total of $8.34M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 30, 2022.

When was the latest funding round of Yuimedi?

Yuimedi's latest funding was a $***** Seed round on Feb 18, 2026, with participation from 7 investors. Its primary sector is Data as a Service. Globally, the Data as a Service sector has seen $1.43B in funding in 2026 to date.

Where does Yuimedi rank among its competitors?

Yuimedi ranks 3rd amongst 66 active competitors, of which 8 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Memed, which secured $15.9M in May, 2026.

Who are the top competitors of Yuimedi?

Yuimedi's top competitors include Memed, Epocrates and MMIT Network. Among them, Memed secured the most recent funding round in May, 2026.

Yuimedi - 2026 Company Profile, Team, Funding & Competitors

Yuimedi is a seed company based in Minato City (Japan), founded in 2020. It operates as a Provider of medical data analysis platform to enhance the healthcare system. Yuimedi has raised $8.34M in funding from DG Daiwa Ventures. The company has 66 active competitors, including 8 funded and 6 that have exited. Its top competitors include companies like Memed, Epocrates and MMIT Network.

Company Details

Provider of medical data analysis platform to enhance the healthcare system. It offers a platform to support analytical research using medical data and prescription decisions by doctors and provides consulting on medical data, and operation services. It specialize in data cleansing and standardization using the OMOP Common Data Model, enabling the comparison and integration of medical data across systems and institutions.

Key Metrics

Founded Year

2020

Location

Minato City, Japan

Stage

Seed

Total Funding

$8.34M in 4 rounds

Latest Funding Round

Seed, Feb 18, 2026, $*****

Investors

DG Daiwa Ventures & 9 more

Ranked

3^rd among 66 active competitors

Employee Count

15 as on Jun 30, 2026

Similar Companies

Memed & 85 more

View Yuimedi's full profile

Yuimedi has raised a total funding of $8.34M over 4 rounds. Its first funding round was on Nov 30, 2022. Its latest funding round was a Seed round on Feb 18, 2026 for $*****. 7 investors participated in its latest round. Yuimedi has 10 institutional investors.

Here is the list of recent funding rounds of Yuimedi:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 18, 2026	9725410	Seed	1737310	7753107	8543656	2045534
Jul 02, 2024	8182806	Seed	5451553	8202856	3201086	Aozora
Jul 02, 2024	9891157	Venture Debt	8135587	4233154	1132051	DG Daiwa Ventures & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Yuimedi's funding rounds and investors

Yuimedi's employee count trend

Yuimedi has 15 employees as of Jun 26. Here is Yuimedi's employee count trend over the years:

Uncover Yuimedi's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Yuimedi include Memed, Epocrates and MMIT Network. Here is the list of Top 10 competitors of Yuimedi, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Memed 2012, Sao Paulo (Brazil), Series C	Application with curated drug information used by physicians	$97.9M	DNA Capital, Temasek & 13 others	57/100
2nd	Epocrates 1998, San Mateo (United States), Acquired	Clinical decision support tool providing continually updated medical content for clinicians	$35M	Millennium Technology Value Partners, Saints Capital ... & 8 others	54/100
3rd	Yuimedi 2020, Minato City (Japan), Seed	Provider of medical data analysis platform to enhance the healthcare system	$8.34M	Sumitomo Mitsui Trust Bank, SMBC Venture Capital ... & 8 others	52/100
4th	MMIT Network 1994, Yardley (United States), Acquired	Provider of data, analytics, and software for pharmaceutical and healthcare sectors	$27.4M	HgCapital Trust, Susquehanna Growth Equity ... & 1 others	46/100
5th	Wolters Kluwer Clinical Drug Information 1978, Hudson (United States), Unfunded	Drug decision support solutions empowering healthcare professionals with trusted drug information	-	-	43/100
6th	Pharmacodia 2013, Beijing (China), Series B	Online database solutions for pharmaceutical R&D	$14.5M	Yuan Ming Capital, Shanghai Hanshi Investment Management Co ... & 2 others	40/100
7th	Posos 2018, Amiens (France), Series A	AI-based drug information and patient profiling tool for healthcare professionals	$9.54M	Caphorn, Sylvain Zimmer & 4 others	39/100
8th	First Databank 1982, Lincolnton (United States), Unfunded	Medication decision support and drug database solutions for healthcare improvement	-	-	38/100
9th	DIMS 2014, Dhaka (Bangladesh), Unfunded	A mobile based Drug Information Management System	-	-	38/100
10th	Pharma Intelligence 1998, London (United Kingdom), Acquired	Provides tools and solutions for pharmaceutical management	-	-	37/100